CAV3
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CAV3</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">N-terminal scaffolding domain (CSD)</td>
<td>1-81</td>
</tr>
<tr>
<td class="label">Hydrophobic membrane domain</td>
<td>82-109</td>
</tr>
<tr>
<td class="label">C-terminal domain</td>
<td>110-151</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Dystrophin</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">β-Dystroglycan</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">nNOS</td>
<td>Scaffold</td>
</tr>
<tr>
<td class="label">Integrins</td>
<td>Coordinate</td>
</tr>
<tr>
<td class="label">G proteins</td>
<td>Scaffold</td>
</tr>
<tr>
<td class="label">Mutation Type</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Nonsense</td>
<td>Truncated protein</td>
</tr>
<tr>
<td class="label">Missense</td>
<td>Altered function</td>
</tr>
<tr>
<td class="label">Frameshift</td>
<td>No functional protein</td>
</tr>
<tr>
<td class="label">Splice site</td>
<td>Abnormal splicing</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Type</td>
</tr>
<tr>
<td class="label">CAV1</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">DMD</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">DAG1</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">nNOS</td>
<td>Scaffold</td>
</tr>
<tr>
<td class="label">G proteins</td>
<td>Scaffold</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
CAV3 encodes Caveolin-3, the muscle-specific member of the caveolin protein family. While CAV1 and CAV2 are expressed ubiquitously, CAV3 is highly enriched in skeletal muscle, cardiac muscle, and to a lesser extent in neurons. As the muscle-specific caveolin, CAV3 plays critical roles in maintaining sarcolemmal integrity, organizing signaling complexes at the plasma membrane, and coordinating the assembly of the dystrophin-glycoprotein complex at the neuromuscular junction[@Parton2018][@Stern2019].
Mutations in CAV3 cause a spectrum of muscular dystrophies ranging from mild limb-girdle muscular dystrophy type 1C (LGMD1C) to severe rippling muscle disease and familial hypertrophic cardiomyopathy. These disorders highlight the essential structural and signaling functions of caveolin-3 in muscle cells. Beyond its role in muscle disease, emerging evidence suggests CAV3 may play neuroprotective roles in the brain, with implications for understanding neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD)[@Woodman2004][@Gazzerro2010].
Molecular Structure and Function
Protein Architecture
CAV3 shares structural homology with CAV1 but has distinct features:
The caveolin-3 protein (~18 kDa) forms higher-order oligomers that are essential for caveolae formation in muscle cells. Key differences from CAV1 include:
- Tissue-specific expression
- Alternative regulatory mechanisms
- Distinct protein interactions
Caveolae in Muscle
In muscle cells, caveolae serve multiple functions:
Membrane organization: Stabilize sarcolemmal structure
Signal transduction: Organize signaling complexes
Mechanical sensing: Detect stretch and force
Endocytosis: Regulate membrane traffickingRole in the Dystrophin-Glycoprotein Complex
DGC Assembly
CAV3 is a component of the dystrophin-glycoprotein complex (DGC):
Mermaid diagram (expand to render)
Interactions
CAV3 interacts with:
Disease Associations
Limb-Girdle Muscular Dystrophy Type 1C (LGMD1C)
CAV3 mutations cause LGMD1C[@Gazzerbo2010][@Taguchi2005][@Schj不然2007]:
Clinical features:
- Childhood to adult onset
- Proximal muscle weakness
- Elevated creatine kinase
- Variable severity
Pathogenesis:
- Loss of caveolin-3 function
- Disrupted caveolae formation
- DGC dysfunction
- Impaired mechanotransduction
Rippling Muscle Disease
CAV3 mutations can cause rippling muscle disease:
- Muscle rippling upon movement
- Muscle hypertrophy
- Myalgia
- Often mild phenotype
Familial Hypertrophic Cardiomyopathy
CAV3 mutations associated with:
- Cardiac muscle involvement
- Hypertrophic changes
- Arrhythmias
Neuromuscular Junction
CAV3 functions at the NMJ:
Postsynaptic organization: Helps cluster ACh receptors
Signal modulation: Regulates postsynaptic signaling
Maintenance: Long-term NMJ stability
Dystrophin connection: Links to cytoskeletonRole in the Nervous System
Neuronal Expression
While predominantly muscle-expressed, CAV3 has neuronal roles:
- Motor neurons: At neuromuscular junctions
- Sensory neurons: In peripheral ganglia
- Central neurons: Lower expression
Implications for Neurodegeneration
CAV3 may influence neurodegenerative processes:
Alzheimer's Disease:
- Caveolin functions in APP processing
- Cholesterol metabolism relevance
- Synaptic membrane organization
Parkinson's Disease:
- May affect α-synuclein interactions
- Membrane dynamics in dopaminergic neurons
- Mitochondrial function connections
Structure-Function Relationships
Disease Mutations
CAV3 mutations fall into several categories[@Galbiati2001]:
Critical Regions
Functional domains include:
- N-terminus: Signaling protein binding
- Membrane domain: Oligomerization
- C-terminus: Stability
Therapeutic Implications
Gene Therapy Approaches
Potential therapeutic strategies:
AAV-mediated delivery: Systemic CAV3 expression
Small molecules: Stabilize mutant caveolin-3
Exon skipping: Bypass nonsense mutations
Protein therapy: Recombinant caveolin-3Challenges
- Muscle-specific targeting
- Immune response to overexpressed protein
- Achieving therapeutic levels
Expression and Regulation
Tissue Distribution
CAV3 expression:
- Skeletal muscle: Very high
- Cardiac muscle: High
- Smooth muscle: Moderate
- Neurons: Low to moderate
- Brain: Very low
Transcriptional Control
CAV3 is regulated by:
- MyoD family transcription factors
- Serum response factor (SRF)
- Mechanical stress
Interaction Network
CAV3 interacts with:
Research Directions
Unresolved Questions
Complete functions in muscle
Neuronal roles in CNS
Therapeutic delivery methodsEmerging Research
- Gene therapy: AAV delivery approaches
- Patient models: iPSC-derived muscle
- Structural studies: Cryo-EM
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Limb-Girdle Muscular Dystrophy](/diseases/limb-girdle-muscular-dystrophy)
- [Caveolin-3 Protein](/proteins/cav3-protein)
- [CAV1](/genes/cav1) - Related caveolin
- [CAV2](/genes/cav2) - Related caveolin
- [Neuromuscular Junction](/mechanisms/neuromuscular-junction)
- [Dystrophin-Glycoprotein Complex](/mechanisms/dystrophin-complex)
External Links
- [Ensembl: ENSG00000142937](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000142937)
- [UniProt: P51697](https://www.uniprot.org/uniprot/P51697)
- [GeneCards: CAV3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CAV3)
- [OMIM: 601253](https://www.omim.org/entry/601253)
- [NCBI Gene: 859](https://www.ncbi.nlm.nih.gov/gene/859)
References
[Parton & del Pozo, Caveolae as plasma membrane sensors (2018)](https://doi.org/10.1038/s41580-018-0003-4)
[Stern et al., Caveolin functions in development and disease (2019)](https://doi.org/10.1093/hmg/ddz108)
[Woodman et al., Muscle-specific caveolin-3 (2004)](https://doi.org/10.1152/ajpcell.00264.2004)
[Gazzerro et al., Caveolin-3 in muscular dystrophy (2010)](https://doi.org/10.1212/WNL.0b013e3181eee9f0)
[Galbiati et al., Caveolin-3 disease mutations (2001)](https://doi.org/10.1093/hmg/10.18.1805)
[Taguchi et al., CAV3 mutations causing LGMD (2005)](https://doi.org/10.1016/j.braindev.2004.12.008)
[Schj不然 et al., Caveolin-3 and LGMD clinical spectrum (2007)](https://doi.org/10.1093/brain/awp277)
[Sotgia et al., Caveolin-3 and neuronal function (2000)](https://doi.org/10.1002/(SICI)1097-4652(200006)183:3<349::AID-JCP3>3.0.CO;2-T)
[Trimmer et al., Caveolin-1 in lipid metabolism (2019)](https://doi.org/10.1152/physrev.00037.2018)
[Head et al., Caveolin-1 in neurodegenerative diseases (2011)](https://doi.org/10.1016/j.yjmcc.2011.02.012)
[Williams & Lisanti, The caveolin genes (2004)](https://doi.org/10.1016/j.tcb.2004.08.005)
[Patel et al., Caveolae as signal transduction organizers (2008)](https://doi.org/10.1146/annurev.pharmtox.48.121505.105224)Pathway Diagram
The following diagram shows the key molecular relationships involving CAV3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)